Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sushanta Chhatar
Observed names:
Chhatar, Sushanta,
Sushant Chhatar
Institutions:
Tata Institute of Fundamental Research,
Birla Institute of Technology and Science - Hyderabad Campus,
Birla Institute of Technology and Science, Pilani
Observed institutions:
Tata Institute of Fundamental Research,
Birla Institute of Technology and Science - Hyderabad Campus,
National Centre for Cell Science,
Birla Institute of Technology and Science, Pilani
ORCID:
0000-0002-3247-6359
Observed ORCID:
0000-0002-3247-6359
OpenAlex ID:
A5049998649
Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor
2019
·
Sourav Paul
, Sushanta Chhatar
, et al.
·
Journal for ImmunoTherapy of Cancer
·
169
PDF
Role of adrenergic receptor signalling in neuroimmune communication
2021
·
Sushanta Chhatar
, Girdhari Lal
·
Current Research in Immunology
·
159
PDF
Potent Ruthenium–Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to In Vivo Evaluation in Zebrafish
2022
·
Manikandan M
, Shubhankar Gadre
, et al.
·
Journal of Medicinal Chemistry
·
38
A Rationally Designed Bimetallic Platinum (II)‐Ferrocene Antitumor Agent Induces Non‐Apoptotic Cell Death and Exerts in Vivo Efficacy
2022
·
Shubhankar Gadre
, M. Manikandan
, et al.
·
Chemistry - A European Journal
·
35
The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity
2023
·
Tushar Ranjan Panda
, Manikandan M
, et al.
·
Angewandte Chemie International Edition
·
24
PDF
A hydrolytically stable oxo-rhenium( v ) antitumor agent for synergistic combination therapy with cisplatin: from synthesis and mechanistic studies to toxicity assessment in zebrafish
2023
·
Shreyas P. Vaidya
, Manikandan M
, et al.
·
Inorganic Chemistry Frontiers
·
12
The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity
2023
·
Tushar Ranjan Panda
, Manikandan M
, et al.
·
Angewandte Chemie
·
7
Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability
2023
·
Manikandan M
, Sushanta Chhatar
, et al.
·
Chemistry - A European Journal
·
5
Analysis of Antiangiogenic Potential and Cell Death Mechanism of a Kinetically Inert Platinum Antitumor Agent
2024
·
Manikandan M
, Sushanta Chhatar
, et al.
·
ACS Medicinal Chemistry Letters
·
4
PDF
Frontispiece: The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity
2023
·
Tushar Ranjan Panda
, Manikandan M
, et al.
·
Angewandte Chemie International Edition
·
1
CCDC 2535857: Experimental Crystal Structure Determination
2026
·
Dutta, Amlanjyoti
, Das, Shubhangi
, et al.
·
The Cambridge Structural Database
Reactivity-Guided Selective Covalent Targeting of mtDNA over nDNA by an NHC–Rhenium Complex Triggers Bioenergetic Collapse in Cancer Cells
2026
·
Amlanjyoti Dutta
, Shubhangi Das
, et al.
·
JACS Au
Thiamine pyrophosphate-dependent enzymes in Toxoplasma gondii and functional significance of an apicoplast-localized pyruvate dehydrogenase
2026
·
Sushanta Chhatar
, Ketan Kumar
, et al.
·
Methods in enzymology on CD-ROM/Methods in enzymology
Frontispiz: The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity
2023
·
Tushar Ranjan Panda
, Manikandan M
, et al.
·
Angewandte Chemie
PDF
CCDC 2190222: Experimental Crystal Structure Determination
2022
·
M, Manikandan
, Gadre, Shubhankar
, et al.
·
The Cambridge Structural Database
505 Activation of NK T cells promote the inflammatory tumor microenvironment and control the growth of solid tumor
2020
·
Sourav Paul
, Amrita Mishra
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
16
Citation count:
454
H-index:
7
I10-index:
6
Year
Topic
Type